Recombinant IL-6R (Tocilizumab Biosimilar) 抗体
-
- 抗原 See all IL-6R (Tocilizumab Biosimilar) products
- IL-6R (Tocilizumab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Mammalian Cells
- Expression System
- Mammalian cells
-
克隆类型
- 单克隆
-
标记
- This IL-6R (Tocilizumab Biosimilar) antibody is un-conjugated
-
应用范围
- ELISA
- 原理
- Tocilizumab Biosimilar - Anti-IL-6R mAb
- 产品特性
- Antibody Type: IgG1Kappa
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 质量等级
- Research Grade
- 亚型
- IgG1 kappa
-
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS pH 7.5
- 储存条件
- 4 °C,-20 °C
- 储存方法
- 4°C for short term, -20°C for long term
-
- 抗原
- IL-6R (Tocilizumab Biosimilar)
- Abstract
- IL-6R (Tocilizumab Biosimilar) 产品
- 别名
- CD126 antibody, IL-6R-1 antibody, IL-6RA antibody, IL6Q antibody, IL6RA antibody, IL6RQ antibody, gp80 antibody, interleukin 6 receptor antibody, IL6R antibody
- 物质类
- Biosimilar
- 背景
-
Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. - CAS-编号
- 375823-41-9
-